CRSP
CRISPR Therapeutics AG
CRISPR Therapeutics AG (CRSP) has 8 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jun 1, 2026.
Insiders have net sold $2.3M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Samarth Kulkarni
- Employees:393
- HQ:Zug, ZG, CH
- IPO:2016-10-19
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.3M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$4.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 3,786 | $211K | Jun 1 | SEC ↗ | |
| General Counsel and Secretary | Sale | 3,182 | $149K | Mar 24 | SEC ↗ | |
| Chief Financial Officer | Sale | 3,708 | $173K | Mar 24 | SEC ↗ | |
| Chief Executive Officer | Sale | 10,020 | $469K | Mar 24 | SEC ↗ | |
Prasad RajuFirst filing | Chief Financial Officer | Sale | 9,869 | $476K | Mar 17 | SEC ↗ |
Kulkarni SamarthFirst filing | Chief Executive Officer | Sale | 10,349 | $499K | Mar 17 | SEC ↗ |
Patel NaimishFirst filing | Chief Medical Officer | Sale | 3,150 | $152K | Mar 17 | SEC ↗ |
KASINGER JAMES R.First filing | General Counsel and Secretary | Sale | 3,450 | $166K | Mar 17 | SEC ↗ |
Related companies
CRISPR Therapeutics AG is in the Healthcare sector.